ALNYLAM PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Property, Plant and Equipment, Gross of $835.85 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-12
- 2025-12-31: Property, Plant and Equipment, Gross $835.85M.
- 2024-12-31: Property, Plant and Equipment, Gross $773.15M.
- 2023-12-31: Property, Plant and Equipment, Gross $749.13M.
- 2022-12-31: Property, Plant and Equipment, Gross $696.94M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $835.85M 10-K · filed 2026-02-12 |
| 2024-12-31 | $773.15M 10-K · filed 2026-02-12 |
| 2023-12-31 | $749.13M 10-K · filed 2025-02-13 |
| 2022-12-31 | $696.94M 10-K · filed 2024-02-15 |
| 2021-12-31 | $642.37M 10-K · filed 2023-02-23 |
| 2020-12-31 | $569.38M 10-K · filed 2022-02-10 |
| 2019-12-31 | $501.34M 10-K · filed 2021-02-11 |
| 2018-12-31 | $400.14M 10-K · filed 2020-02-13 |
| 2017-12-31 | $249.25M 10-K · filed 2019-02-14 |
| 2016-12-31 | $175.58M 10-K · filed 2018-02-15 |
| 2015-12-31 | $79.31M 10-K · filed 2017-02-15 |
| 2014-12-31 | $67.83M 10-K · filed 2016-02-12 |
| 2013-12-31 | $57.76M 10-K · filed 2015-02-13 |
| 2012-12-31 | $55.27M 10-K · filed 2014-02-20 |
| 2011-12-31 | $45.57M 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |